Modeling of ligand binding to G protein coupled receptors: cannabinoid CB1, CB2 and adrenergic β2AR

被引:0
|
作者
Dorota Latek
Michal Kolinski
Umesh Ghoshdastider
Aleksander Debinski
Rafal Bombolewski
Anita Plazinska
Krzysztof Jozwiak
Slawomir Filipek
机构
[1] University of Warsaw,Faculty of Chemistry
[2] Medical University of Lublin,Department of Chemistry
[3] Goethe-University of Frankfurt/Main,Centre for Biomolecular Magnetic Resonance, Institute for Biophysical Chemistry
[4] University of Warsaw,Faculty of Physics
[5] International Institute of Molecular and Cell Biology,undefined
来源
Journal of Molecular Modeling | 2011年 / 17卷
关键词
Cannabinoid receptors; Docking; Fenoterol; GPCRs; Molecular dynamics; Molecular switches;
D O I
暂无
中图分类号
学科分类号
摘要
Cannabinoid and adrenergic receptors belong to the class A (similar to rhodopsin) G protein coupled receptors. Docking of agonists and antagonists to CB1 and CB2 cannabinoid receptors revealed the importance of a centrally located rotamer toggle switch and its possible participation in the mechanism of agonist/antagonist recognition. The switch is composed of two residues, F3.36 and W6.48, located on opposite transmembrane helices TM3 and TM6 in the central part of the membranous domain of cannabinoid receptors. The CB1 and CB2 receptor models were constructed based on the adenosine A2A receptor template. The two best scored conformations of each receptor were used for the docking procedure. In all poses (ligand-receptor conformations) characterized by the lowest ligand-receptor intermolecular energy and free energy of binding the ligand type matched the state of the rotamer toggle switch: antagonists maintained an inactive state of the switch, whereas agonists changed it. In case of agonists of β2AR, the (R,R) and (S,S) stereoisomers of fenoterol, the molecular dynamics simulations provided evidence of different binding modes while preserving the same average position of ligands in the binding site. The (S,S) isomer was much more labile in the binding site and only one stable hydrogen bond was created. Such dynamical binding modes may also be valid for ligands of cannabinoid receptors because of the hydrophobic nature of their ligand-receptor interactions. However, only very long molecular dynamics simulations could verify the validity of such binding modes and how they affect the process of activation.
引用
收藏
页码:2353 / 2366
页数:13
相关论文
共 50 条
  • [41] Reporter assays for human cannabinoid CB1 and CB2 receptors for the identification of novel agonists
    Green, A
    O'Shaughnessy, C
    Disney, G
    Marshall, F
    BRITISH JOURNAL OF PHARMACOLOGY, 1999, 126
  • [42] Expression of cannabinoid receptors CB1 and CB2 in canine cutaneous mast cell tumours
    Rinaldi, Valentina
    Boari, Andrea
    Ressel, Lorenzo
    Bongiovanni, Laura
    Crisi, Paolo Emidio
    Cabibbo, Emanuele
    Finotello, Riccardo
    RESEARCH IN VETERINARY SCIENCE, 2022, 152 : 530 - 536
  • [43] DISTINCT ROLES OF CB1 AND CB2 CANNABINOID RECEPTORS IN HUMAN BRONCHIAL EPITHELIAL CELLS
    Elzinga, C. R. S.
    Roscioni, S. S.
    Gkoumassi, E.
    Van der Horn, H. J.
    Warnders, F. J.
    Van Streun, E. L. P.
    Nelemans, S. A.
    Meurs, H.
    Zaagsma, J.
    Schmidt, M.
    NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY, 2009, 379 (02) : 202 - 202
  • [44] Control of spasticity in a multiple sclerosis model is mediated by CB1, not CB2, cannabinoid receptors
    Pryce, G.
    Baker, D.
    BRITISH JOURNAL OF PHARMACOLOGY, 2007, 150 (04) : 519 - 525
  • [45] Allosteric modulators targeting cannabinoid cb1 and cb2 receptors: implications for drug discovery
    Gado, Francesca
    Meini, Serena
    Bertini, Simone
    Digiacomo, Maria
    Macchia, Marco
    Manera, Clementina
    FUTURE MEDICINAL CHEMISTRY, 2019, 11 (15) : 2019 - 2037
  • [46] COMPARISON OF THE PHARMACOLOGY AND SIGNAL-TRANSDUCTION OF THE HUMAN CANNABINOID CB1 AND CB2 RECEPTORS
    FELDER, CC
    JOYCE, KE
    BRILEY, EM
    MANSOURI, J
    MACKIE, K
    BLOND, O
    LAI, Y
    MA, AL
    MITCHELL, RL
    MOLECULAR PHARMACOLOGY, 1995, 48 (03) : 443 - 450
  • [47] Reduced Noradrenergic Signaling in the Spleen Capsule in the Absence of CB1 and CB2 Cannabinoid Receptors
    Tyrell J. Simkins
    David Fried
    Kevin Parikh
    James J. Galligan
    John L. Goudreau
    Keith J. Lookingland
    Barbara L. F. Kaplan
    Journal of Neuroimmune Pharmacology, 2016, 11 : 669 - 679
  • [48] Reduced Noradrenergic Signaling in the Spleen Capsule in the Absence of CB1 and CB2 Cannabinoid Receptors
    Simkins, Tyrell J.
    Fried, David
    Parikh, Kevin
    Galligan, James J.
    Goudreau, John L.
    Lookingland, Keith J.
    Kaplan, Barbara L. F.
    JOURNAL OF NEUROIMMUNE PHARMACOLOGY, 2016, 11 (04) : 669 - 679
  • [49] Homology models of the cannabinoid CB1 and CB2 receptors.: A docking analysis study
    Montero, C
    Campillo, NE
    Goya, P
    Páez, JA
    EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2005, 40 (01) : 75 - 83
  • [50] EXPRESSION OF CANNABINOID 1 (CB1) AND CANNABINOID 2 (CB2) RECEPTOR AND EFFECTS OF CB1/CB2 RECEPTOR AGONISTS ON DETRUSOR OVERACTIVITY ASSOCIATED WITH BLADDER OUTLET OBSTRUCTION IN RATS
    Cho, K. J.
    Kim, S. D.
    Seo, J. T.
    Kim, S. H.
    Kim, J. C.
    NEUROUROLOGY AND URODYNAMICS, 2013, 32 (06) : 926 - 927